The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Ehealth Inc

Nasdaq: EHTH
Last

(U.S.) $15.07

Today's change+0.93 +6.58%
Updated September 2 4:00 PM EDT. Delayed by at least 15 minutes.
 

Ehealth Inc

Nasdaq: EHTH
Last

(U.S.) $15.07

Today's change+0.93 +6.58%
Updated September 2 4:00 PM EDT. Delayed by at least 15 minutes.

Ehealth Inc crosses above 200-day moving average

Ehealth Inc closed up sharply Wednesday, rallying (U.S.)$0.93 or 6.58% to (U.S.)$15.07 and crossing above its 200-day moving average. Over the last five days, shares have gained 9.52%, but are down 39.53% for the last year to date. Shares have underperformed the S&P 500 by 40.78% during the last year.

Key company metrics

  • Open(U.S.) $14.63
  • Previous close(U.S.) $14.14
  • High(U.S.) $15.15
  • Low(U.S.) $14.30
  • Bid / Ask(U.S.) $12.50 / (U.S.) $17.65
  • YTD % change-39.53%
  • Volume193,685
  • Average volume (10-day)191,654
  • Average volume (1-month)199,911
  • Average volume (3-month)184,245
  • 52-week range(U.S.) $8.81 to (U.S.) $29.20
  • Beta1.22
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward646.78×
  • Forward PEG86.24×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.79
Updated September 2 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-7.48%

Ehealth Inc has a net profit margin of -7.48%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.47%Sector:FinancialsIndustry:Insurance - Life & Health
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue40614541
Total other revenue--------
Total revenue40614541
Gross profit39594440
Total cost of revenue1211
Total operating expense34635937
Selling / general / administrative33565836
Research & development--------
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)04----
Other operating expenses, total--------
Operating income6-2-144
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax6-2-144
Income after tax6-2-192
Income tax, total0052
Net income6-2-192
Total adjustments to net income--------
Net income before extra. items6-2-192
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items6-2-192
Inc. avail. to common incl. extra. items6-2-192
Diluted net income6-2-192
Dilution adjustment--------
Diluted weighted average shares18181818
Diluted EPS excluding extraordinary itemsvalue per share0.32-0.12-1.080.08
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.320.05-1.080.08